HERE'S ANOTHER ONE I JUST GOT TODAY...
At some point in the past you used the NexProfiler Treatment Option Tool for Breast Cancer. At the time you registered for this treatment decision tool, you indicated that you would be interested in being contacted by NexCura, which operates the NexProfiler Tool for Cancer, for opportunities to participate in market research.
We recognize that dealing with breast cancer can be a difficult experience and that you may not want to participate in market research. If that is the case, please delete this e-mail.
We are writing to let you know that a research group will be conducting phone interviews with breast cancer patients between October 25th and November 3rd. The research group is offering
$75 to patients who qualify and participate in a 45-minute phone interview.
In order to participate in these interviews, you must meet
ONE of the following criteria:
Be a breast cancer patient who is
currently being treated with Abraxane
OR
Be a breast cancer patient who has
discontinued treatment with Abraxane
OR
Be a breast cancer patient who is
currently being treated a with chemotherapy other than Abraxane
There are additional criteria required for participation. In order to see if you qualify, we invite you to take a brief pre-screening survey (approximately 9 questions) by
clicking here.
If the link doesn't work, please paste the following url into your browser:
https://survey.nexcura.com/Survey.as...e-4bd83f455a05
Any one of these questions may disqualify you from participation, but you may be asked all 9 questions before finding out if you qualify to participate in the phone interview. All of the data collected (if qualified) will be passed over to the market research group hosting the study. If you qualify, the market research group will contact you to schedule the interview.
This study is strictly for research purposes.
Participation in these research interviews is limited and there may be additional criteria needed to participate. If you wish to share this opportunity with others who may be eligible in your area, please forward this message to them.
Questions about this research?
You may contact us at:
Patient Information Services
NexCura, A Thomson Business
1725 Westlake Ave. N., Suite 300
Seattle, WA 98109
E-mail:
interviews@education.nexcura.com
Phone: 1-877-422-3228
If you wish to review NexCura's Privacy Statement, visit:
http://www.nexcura.com/nexcura/Nexcura_Privacy.asp